GCR Nominates Axinn for Firm of the Year and Litigator of the Year
February 17, 2021
Global Competition Review has nominated Axinn for two GCR Awards for excellence in 2020.
Axinn earned a nomination for "Firm of the Year - Americas" due to its work on some of today’s most noteworthy matters, including representing Google in investigations by the U.S. Department of Justice and State of Texas; Thermo Fisher in its proposed $12.5 billion acquisition of QIAGEN NV; Tufts Health Plan in its merger with Harvard Pilgrim Health Care; Tyson Foods in multiple treble damages class action claims; and Alvogen in the Generic Pharmaceuticals Antitrust Pricing Litigation.
Axinn partner Rachel Adcox earned a second nomination for" Litigator of the Year" for her work as lead counsel on several major class action claims and multi-district antitrust litigation cases, including her representation of Tyson Foods in multiple major treble-damage class action litigations and regulatory investigations alleging industry-wide conspiracies to raise the prices of broiler chickens, pork, turkey, and beef, as well as a conspiracy to depress broiler grower pay. She is also lead counsel defending Alvogen Inc. in the sprawling Generic Drugs MDL, a suit alleging participation in an industry-wide conspiracy to raise prices of generic medications through the allocation of markets.
The finalists were chosen by Global Competition Review’s editorial team and GCR readers will decide the winners through an online vote. The winners will be announced in a series of special reports that GCR will begin publishing in April.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
IPWatchdog Sixth Annual Live Conference
Speaking Engagement
Intellectual Property
Squires Again Broadens Discretion for Post-Grant Proceedings
Axinn Viewpoints
Intellectual Property
ABA White Collar Crime Institute 2026
Speaking Engagement
Back to the Well: FDA’s Draft Guidance on New Clinical Investigation Exclusivity
Axinn Viewpoints
Intellectual Property
Mother, May I? The Use of Prior Approval Requirements in Merger Settlements
Podcast
Antitrust
The Curtain Rises Again on FTC Act Section 5
Axinn Viewpoints
Jeny Maier Named Finalist for Managing Partner of the Year in 2026 Women, Influence & Power in Law Awards
Awards & Recognitions
DOJ Serves Up a Statement of Interest with a Side of Fries
Axinn Viewpoints
Antitrust